Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - KIWA BIO-TECH PRODUCTS GROUP CORPFinancial_Report.xls
10-Q - 10-Q - KIWA BIO-TECH PRODUCTS GROUP CORPv386345_10q.htm
EX-31.2 - EXHIBIT 31.2 - KIWA BIO-TECH PRODUCTS GROUP CORPv386345_ex31-2.htm
EX-32.2 - EXHIBIT 32.2 - KIWA BIO-TECH PRODUCTS GROUP CORPv386345_ex32-2.htm
EX-31.1 - EXHIBIT 31.1 - KIWA BIO-TECH PRODUCTS GROUP CORPv386345_ex31-1.htm

 

Exhibit 32.1

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

     In connection with the Quarterly Report of Kiwa Bio-Tech Products Group Corporation (the “Company”) on Form 10-Q for the quarter ended June 30, 2014 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Wei Li, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

 

 (1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

 

 (2)  The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company for the period presented therein.

 

Date: August 19, 2014

 

By: /s/ Wei Li  
  Wei Li  
  Principal Executive Officer